LIF and Familial prostate cancer: Importantly, PMN-MDSCs and, to a lesser extent, M-MDSCs isolated from the blood of prostate cancer patients show high surface levels of LIF receptor and respond to LIF stimulation with STAT3 activation and increased T-cell inhibition.